Skip to content

AMLXAMYLYX PHARMACEUTICALS INC

CUSIP 03237H101 · common stock

3 tracked investors held AMYLYX PHARMACEUTICALS INC (AMLX) at the end of Q3 2026, worth $442.9M in total. The largest holder was Perceptive Advisors, with 5.4% of its portfolio. RA Capital Management opened a new position this quarter.

Holders · Q3 2026
3
New holders
1
Value held
$442.9M
Quarter-end price (est.)
$29.10

Investors holding AMLX · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
5.36%10,573,735$307.7MADD+26.9%
RA Capital Management
RA Capital Management, L.P.
1.25%4,279,341$124.5MNEW
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.45%366,968$10.7MREDUCE-25.8%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026310$442.9M$29.10
Q2 2026200$158.6M$17.96
Q1 2026200$129.1M$13.90
Q4 2025200$110.8M$12.08